Different incidence of interstitial lung disease according to different kinds of EGFR-tyrosine kinase inhibitors administered immediately before and/or after anti-PD-1 antibodies in lung cancer.

Different incidence of interstitial lung disease according to different kinds of EGFR-tyrosine kinase inhibitors administered immediately before and/or after anti-PD-1 antibodies in lung cancer. — المؤلف: Uchida, Takahiro — Thoracic cancer 20200312

المؤلف
Uchida, Takahiro
النشر
Thoracic cancer 20200312
الوصف
975-979 p.
الموضوعات
Acrylamides؛ Adult؛ Afatinib؛ Aged؛ Aged, 80 and over؛ Aniline Compounds؛ Antineoplastic Agents, Immunological؛ Female